Figure 2
From: Prognostic value of PTEN loss in men with conservatively managed localised prostate cancer
Prostatic adenocarcinoma showing PTEN-deficient (A) and PTEN-positive (B) staining by immunohistochemistry.
Figure 2 | British Journal of Cancer
